Nippon India Pharma Fund

100
Min SIP
5,000
Min Lumpsum
1.05 %
Expense Ratio
Rating
4,510
Fund Size (in Cr)
10 Years
Fund Age
Mutual Fund SIP Calculator
Monthly Investment
Max: ₹1,00,000
Investment Period
Yrs
Max: 5 yrs
  • Invested Amount
    --
  • Wealth Gained
    --
  • Expected Amount
    --

Scheme Performance

Returns and Ranks ( as on 31 May 2023 )
1Y1Y 3Y3Y 5Y5Y MaxMax
Trailing Returns 9.3% 16.9% 17.5% 15.6%
Category Average 6.2% 15.4% 13.5% -

Scheme Allocation

By Holding
By Sector
By Asset
Sun Pharma.Inds.
14.36%
Dr Reddy's Labs
7.1%
Lupin
6.93%
Cipla
6.04%
Apollo Hospitals
5.21%
Others
60.36%
Pharmaceuticals & Biotech
76.55%
Healthcare Services
17.93%
Cash & Others
2.38%
Retailing
2.01%
Debt
0.85%
Others
0.28%
Equity
96.77%
Net Curr Ass/Net Receivables
2.38%
Reverse Repos
0.85%
Cash & Cash Equivalents
0%

Advance Ratio

0.15
Alpha
3.68
SD
0.93
Beta
-0.08
Sharpe

Exit Load

Exit Load 1% if redeemed or switchd out on or efore completion of 1 Months from the date of allotment of units. NIl if redeemed or switched out after the completion of 1 Months from the date of allotment of units.

Fund Objective

The Nippon India Pharma Fund is an equity scheme investing in the pharma sector. It was launched on 5th June 2004 by Nippon India Mutual Fund.

The Nippon India Pharma Fund distributes its investments across pharmaceuticals and biotechnology, and healthcare services companies of the pharma sector. It is managed by Sailesh Raj Bhan.

The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity-related or fixed-income securities of companies in the pharmaceutical and related industries. It aims to achieve its objective by investing in companies that meet criteria such as strong management, established performance history, growth potential, and favourable industry economic conditions.

The Nippon India Pharma Fund invests at least 80% of its assets in equity and related instruments. It has the flexibility to invest up to 20% of its assets in debt, money market instruments, REITs, and InvITs.

Pros & Cons

Pros

Cons

Since its inception, the Nippon India Pharma Fund’s annualised returns have consistently beaten its category average and benchmark, the S&P BSE Healthcare TRI. The Nippon India Pharma Fund has a higher beta and standard deviation than its category average, indicating volatility.
It has delivered higher alpha in the past three years than its benchmark and category average, indicating superior performance. As a sector-specific scheme, it limits its investment universe to companies in the pharmaceutical sector, potentially reducing the opportunity for diversification and increasing the risk of an over-concentrated portfolio.
The scheme has demonstrated a better Sharpe ratio than the category average in the last three years, showcasing its ability to generate higher returns per unit of risk. The scheme is tailored for long-term investments, with its strategy and growth prospects aligned for a multi-year time horizon. Therefore, investors must be willing to hold the scheme for an extended period.

 

How to invest in Nippon India Pharma Fund?

5paisa makes it simple and convenient for users to invest in the Nippon India Pharma Fund Direct-Growth. The procedure is straightforward, can be finished quickly, and does not include any paperwork at any point. Invest a few minutes in carrying out the steps listed below:

Step 1: Log in to your 5Paisa Account. If you do not have one, register and create a new 5Paisa account in 3 easy steps. Alternatively, you can download the 5Paisa app on your smartphone for Android or IOS and log in from your device.
Step 2: Search for the Nippon India Mutual Fund scheme that you want to invest in
Step 3: Select the option that is apt for your requirement and risk appetite
Step 4: Select the investment type – SIP (Systematic Investment Plan) or Lumpsum
Step 5: Input the amount that you’d like to invest and proceed with payment by clicking on the ‘Invest Now’ button

That’s it! This sums up the investment process. Once your payment is successful, you can see the Nippon India Mutual Fund reflected in your 5Paisa account in 3-4 working days. If you have selected the SIP option, the chosen amount will get deducted every month starting from the date you have made the payment.

What is the expense ratio of the Nippon India Pharma Fund?

When referring to the Nippon India Pharma Fund Direct-Growth or any other mutual fund, the word “Expense Ratio” refers to the fund’s annual operating expenses as a percentage of its total assets, which can impact a scheme’s returns for investors. A lower expense ratio usually means the fund is less costly and may generate higher returns for the investors.

Who should invest in Nippon India Pharma Fund?

The Nippon India Pharma Fund is ideal for investors seeking long-term capital appreciation and investment in equity and equity-related securities of pharma and related companies. Investors looking to include a focused pharma sector investment in their overall asset allocation strategy should consider this scheme.

The scheme has exceeded the performance of the S&P BSE Healthcare TRI since its inception, with a compound annual growth rate (CAGR) of around 15.4% over the same period, highlighting its annualised growth performance.

The Nippon India Pharma Fund is ideal for those with a long-term investment strategy and a willingness to accept very high levels of risk. It is suitable for investors who have a keen understanding of macro trends and are looking for high-return investments. This fund is not recommended for those who prefer short-term or risk-averse options. Investors should be prepared to hold the scheme for a minimum of 2 to 3 years and must understand that there may be losses even in favourable market conditions.

What are the benefits of investing in the Nippon India Pharma Fund?

● The Nippon India Pharma Fund offers the advantage of having a concentrated portfolio of pharmaceutical companies, increasing the potential for generating alpha and achieving long-term wealth creation.
● The scheme has consistently outperformed its benchmark and category average since its inception, delivering a CAGR of around 15.4%.
● It invests in the pharmaceutical sector, characterised by low capital requirements and strong cash flows, thereby reducing the impact of overall market fluctuations.
● The pharma and healthcare segment is poised for multiple years of steady growth, driven by factors such as increasing domestic demand, boosted exports, stabilising US markets, growth in healthcare services, and insurance penetration.
● The Nippon India Pharma Fund offers a comprehensive investment opportunity, with holdings across key pharmaceutical industry segments, including domestic and international companies, branded and generic drugs, and contract research and manufacturing.
● It adopts a structured approach to managing investment risk, including ongoing market and economic analysis, research investments, and bonds and debentures assigned investment grade ratings by approved rating agencies.

Fund Managers

Sailesh Raj Bhan

Risk-O-Meter

Peer Comparison

Fund Name

AMC Contact Details

Nippon India Mutual Fund
AUM:
2,81,439 Cr
Address:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact:
022-68087000/1860260111
Email ID:
customercare@nipponindiaim.in

Frequently Asked Questions

How to invest in Nippon India Pharma Fund ?

You can invest in Nippon India Pharma Fund in a quick and simple process. Follow the below steps;
  • Login to your 5paisa account, Go to the Mutual Funds section.
  • Search for Nippon India Pharma Fund in the search box.
  • Click on "Start SIP" if you wish to do a SIP or click on “One-time” if you wish to invest a lumpsum amount then click on "Invest Now"

What is the NAV of Nippon India Pharma Fund ?

The NAV of Nippon India Pharma Fund is ₹316.4 as of 31 May 2023.

How to redeem Nippon India Pharma Fund holding ?

You can go to your holding on the app and click on the fund name you will get two options Invest More and Redeem; click on redeem and enter the amount or units you desire to redeem or you can tick on “Redeem all units”.

What is the minimum sip amount of Nippon India Pharma Fund?

The minimum SIP amount of Nippon India Pharma Fund is ₹100

What are the top sectors Nippon India Pharma Fund has invested in??

The top sectors Nippon India Pharma Fund has invested in are
  1. Sun Pharma.Inds. - 14.36%
  2. Dr Reddy's Labs - 7.1%
  3. Lupin - 6.93%
  4. Cipla - 6.04%
  5. Apollo Hospitals - 5.21%

How much returns have Nippon India Pharma Fund generated ?

The Nippon India Pharma Fund has delivered 15.6% since inception

What is the expense ratio of Nippon India Pharma Fund ?

The expense ratio of Nippon India Pharma Fund is 1.05 % as of 31 May 2023.

What is the AUM of Nippon India Pharma Fund?

The AUM of Nippon India Pharma Fund is ₹2,81,439 Cr as of 31 May 2023

What are the top stock holdings of Nippon India Pharma Fund?

The top stock holdings of Nippon India Pharma Fund are
  1. Sun Pharma.Inds. - 14.36%
  2. Dr Reddy's Labs - 7.1%
  3. Lupin - 6.93%
  4. Cipla - 6.04%
  5. Apollo Hospitals - 5.21%
Invest Now